Dumping Syndrome Clinical Trial
Official title:
The Effect of Fat Supplementation on the Appearance of Symptoms Associated With Dumping Syndrome in Patients Undergone Gastric Surgery
The purpose of the study is the investigation of the effect of fat supplement on gastric emptying rate and the appearance of symptoms of Dumping Syndrome in patients who have undergone gastrointestinal- duodenal surgery. Patients who have undergone bariatric surgery have been examined for the presence of the Dumping syndrome, with glucose measurements, the Sigstad's questionnaire and questionnaire of Arts. Patients diagnosed positive, reiterated the examination process in a second meeting consuming an extra fat supplement. The data obtained on the different appointments were compared between the two groups in a cross over design.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | September 2024 |
Est. primary completion date | September 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Patients with Dumping Syndrome Exclusion Criteria: - Patients with diabetes mellitus type 1 and 2 - Patients with impaired balance of fluids and electrolytes - Patients on diuretics pills or corticosteroids or hypoglycemic tablets and Insulin. |
Country | Name | City | State |
---|---|---|---|
Greece | University Hospital Larissa | Larissa |
Lead Sponsor | Collaborator |
---|---|
Larissa University Hospital |
Greece,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Glucose Levels | Blood glucose measurement | before the ingestion of the carbohydrate and fat supplement (baseline) | |
Primary | Glucose Levels | Blood glucose measurement | 30 minutes after the ingestion of the carbohydrate and fat supplement | |
Primary | Glucose Levels | Blood glucose measurement | 60 minutes after the ingestion of the the carbohydrate and fat supplement | |
Primary | Glucose Levels | Blood glucose measurement | 90 minutes after the ingestion of the the carbohydrate and fat supplement | |
Primary | Glucose Levels | Blood glucose measurement | 120 minutes after the ingestion of the the carbohydrate and fat supplement | |
Primary | Sigstad's Questionnaire | Dumping syndrome symptom associated questionnaire | 1st hour after the ingestion of the supplements | |
Primary | Sigstad's Questionnaire | Dumping syndrome symptom associated questionnaire | 2nd hour after the ingestion of the supplements | |
Primary | Arts's Questionnaire | Dumping syndrome symptom associated questionnaire | 1st hour after the ingestion of the supplements | |
Primary | Arts's Questionnaire | Dumping syndrome symptom associated questionnaire | 2nd hour after the ingestion of the supplements |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04028193 -
Fat Supplementation on Dumping Syndrome Associated Symptoms
|
N/A | |
Recruiting |
NCT00543179 -
Treatment of the Dumping Syndrome With Lanreotide Autogel®
|
Phase 4 | |
Not yet recruiting |
NCT04522193 -
Dumping Syndrome and Esophageal Atresia
|
N/A | |
Completed |
NCT02891330 -
Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity
|
N/A | |
Completed |
NCT02525705 -
Dumping Syndrome After Operation of Esophageal Atresia Type III
|
N/A | |
Completed |
NCT01794793 -
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
|
Phase 4 | |
Completed |
NCT03734627 -
Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery
|
||
Terminated |
NCT02836353 -
Metabolic Consequences of Gastrointestinal Surgery
|
N/A | |
Completed |
NCT05057819 -
Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass
|
Phase 4 | |
Completed |
NCT02971631 -
Gastrectomy, Eating Behaviour and GLP-1
|
N/A | |
Completed |
NCT01923649 -
SOMATULINE Autogel 90 mg IN DUMPING SYNDROME
|
Phase 2 |